Pages that link to "Q27012684"
Jump to navigation
Jump to search
The following pages link to Will kinase inhibitors make it as glioblastoma drugs? (Q27012684):
Displaying 14 items.
- New perspectives in glioblastoma antiangiogenic therapy (Q26746028) (← links)
- Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods (Q26853516) (← links)
- Molecular heterogeneity in glioblastoma: potential clinical implications (Q28088605) (← links)
- Lipid metabolism emerges as a promising target for malignant glioma therapy (Q30684049) (← links)
- Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma (Q33591658) (← links)
- Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFα in glioblastoma (Q35800124) (← links)
- Imaging tumor burden in the brain with 89Zr-transferrin (Q37106244) (← links)
- Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates (Q38722183) (← links)
- Kinome-wide shRNA screen identifies the receptor tyrosine kinase AXL as a key regulator for mesenchymal glioblastoma stem-like cells (Q40842765) (← links)
- Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas. (Q43290383) (← links)
- Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials. (Q47161135) (← links)
- A glial blueprint for gliomagenesis. (Q55457034) (← links)
- New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective (Q58801701) (← links)
- Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model (Q90083949) (← links)